Keywords: lexicon, initiates, ph, ii, ibs, trial, lx1031

Lexicon initiates Ph II IBS trial for LX1031

Article | 19 January 2009

Print This

The USA's Lexicon Pharmaceuticals has initiated a Phase II trial of LX1031, its oral drug candidate for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in